palmitoylcarnitine has been researched along with lysophosphatidylcholines in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (42.86) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, KS; Proulx, P | 1 |
| Clark, MA; Egan, RW; Garsetti, DE; Ozgür, LE; Steiner, MR | 1 |
| Arita, M; Kiyosue, T; Sato, T | 2 |
| Critchley, H; Davis, SS; Farraj, NF; Fisher, AN; Illum, L; Johansen, BR; O'Hagan, DT | 1 |
| Classen, J; Deuticke, B; Haest, CW; Tournois, H | 1 |
| Duncan, GP; Patmore, L; Spedding, M | 1 |
| Boscoboinik, D; Epand, RM | 1 |
| Aomine, M; Arita, M; Shimada, T | 1 |
| Bentham, JM; Higgins, AJ; Woodward, B | 1 |
| Okhuysen, CH; Pitts, BJ | 1 |
| Drisdel, RC; Gross, RW; Sobel, BE | 1 |
| Cain, ME; Corr, PB; Crafford, WA; Gross, RW; Snyder, DW; Sobel, BE | 1 |
| Epand, RM; McCallum, CD | 1 |
| Kang, JX; Leaf, A | 1 |
| Abiko, Y; Hara, A; Hashizume, H | 1 |
| Abiko, Y; Hara, A; Hashizume, H; Hayase, N | 1 |
| Harshbarger, CH; Smith, JM; Sondgeroth, KL; Wahler, GM; Ziolo, MT | 1 |
| Fonfria, E; Michel, AD | 1 |
| Benoist, D; Gizurarson, S; Omerovic, E; Redfors, B; Shao, Y | 1 |
| Chen, D; Chen, J; Gao, YQ; Gao, YX; Liao, W; Liu, J; Sun, BD; Xu, G; Yuan, ZB; Zhan, G; Zhang, EL | 1 |
2 review(s) available for palmitoylcarnitine and lysophosphatidylcholines
| Article | Year |
|---|---|
[A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Circulation; Dilazep; Diltiazem; Energy Metabolism; Humans; Lysophosphatidylcholines; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxygen Consumption; Palmitoylcarnitine; Propranolol; Vasodilator Agents | 1996 |
Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Ceramides; Fatty Acids, Nonesterified; Humans; Lipid Metabolism; Lysophosphatidylcholines; Molecular Targeted Therapy; Palmitoylcarnitine | 2014 |
19 other study(ies) available for palmitoylcarnitine and lysophosphatidylcholines
| Article | Year |
|---|---|
Uptake of lysolecithin and other lysins by rat erythrocytes.
Topics: Animals; Erythrocyte Membrane; Erythrocytes; Hemolysis; Isotope Labeling; Lipids; Lysophosphatidylcholines; Palmitoylcarnitine; Rats | 1978 |
Isolation and characterization of three lysophospholipases from the murine macrophage cell line WEHI 265.1.
Topics: Amino Acids; Animals; Cell Line; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Fatty Acids; Lysophosphatidylcholines; Lysophospholipase; Macrophages; Metals; Mice; Palmitoylcarnitine; Phospholipids; Substrate Specificity | 1992 |
Inhibitory effects of palmitoylcarnitine and lysophosphatidylcholine on the sodium current of cardiac ventricular cells.
Topics: Animals; Electrophysiology; Heart; Heart Ventricles; Lysophosphatidylcholines; Myocardium; Palmitoylcarnitine; Sodium | 1992 |
Nasal absorption enhancers for biosynthetic human growth hormone in rats.
Topics: Absorption; Acetylcysteine; Animals; Enzyme-Linked Immunosorbent Assay; Growth Hormone; Humans; Leucine; Lysophosphatidylcholines; Male; Mucus; Nasal Mucosa; Palmitoylcarnitine; Rats; Rats, Inbred Strains; Viscosity | 1990 |
Gramicidin-induced enhancement of transbilayer reorientation of lipids in the erythrocyte membrane.
Topics: Erythrocyte Membrane; Gramicidin; Hemolysis; Humans; Kinetics; Lipid Bilayers; Lysophosphatidylcholines; Membrane Lipids; Palmitoylcarnitine; Phospholipases A; Phospholipases A2; Thermodynamics | 1987 |
Interaction of palmitoyl carnitine with calcium antagonists in myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Carnitine; Cells, Cultured; Chick Embryo; Heart; Lysophosphatidylcholines; Myocardial Contraction; Myocardium; Palmitoylcarnitine | 1989 |
Increased cellular internalization of amphiphiles in a multidrug-resistant CHO cell line.
Topics: Animals; Biological Transport; Carnitine; Cell Line; Cell Membrane; Cricetinae; Cyclosporins; Diffusion; Drug Resistance; Kinetics; Lysophosphatidylcholines; Palmitoylcarnitine; Quinacrine; Solubility; Verapamil | 1989 |
Effects of L-propionylcarnitine on electrical and mechanical alterations induced by amphiphilic lipids in isolated guinea pig ventricular muscle.
Topics: Animals; Carnitine; Electrophysiology; Female; Guinea Pigs; Lysophosphatidylcholines; Male; Microscopy, Electron; Myocardial Contraction; Myocardium; Palmitoylcarnitine; Papillary Muscles | 1988 |
The effects of ischaemia, lysophosphatidylcholine and palmitoylcarnitine on rat heart phospholipase A2 activity.
Topics: Animals; Carnitine; Coronary Disease; In Vitro Techniques; Lysophosphatidylcholines; Male; Myocardium; Palmitoylcarnitine; Perfusion; Phospholipases; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Strains | 1987 |
Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase.
Topics: Animals; Carnitine; Dogs; Lysophosphatidylcholines; Myocardium; Palmitoylcarnitine; Sarcolemma; Sodium Dodecyl Sulfate; Sodium-Potassium-Exchanging ATPase | 1984 |
Rabbit myocardial lysophospholipase-transacylase. Purification, characterization, and inhibition by endogenous cardiac amphiphiles.
Topics: Acyltransferases; Animals; Computers; Kinetics; Lysophosphatidylcholines; Lysophospholipase; Models, Chemical; Molecular Weight; Multienzyme Complexes; Myocardium; Palmitic Acid; Palmitic Acids; Palmitoylcarnitine; Phospholipases; Rabbits; Substrate Specificity | 1983 |
Electrophysiological effects of amphiphiles on canine purkinje fibers. Implications for dysrhythmia secondary to ischemia.
Topics: Acidosis; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Dogs; Electrophysiology; Fatty Acids, Nonesterified; Glycerylphosphorylcholine; Heart Conduction System; Liposomes; Lysophosphatidylcholines; Palmitoylcarnitine; Purkinje Fibers; Surface-Active Agents | 1981 |
Insulin receptor autophosphorylation and signaling is altered by modulation of membrane physical properties.
Topics: 3T3 Cells; Animals; Apolipoprotein A-I; Biophysical Phenomena; Biophysics; Carnitine; Cell Membrane; Dipeptides; Glucose; Insulin; Laurates; Lipid Bilayers; Lysophosphatidylcholines; Mice; Palmitoylcarnitine; Phosphorylation; Receptor, Insulin; Signal Transduction; Sphingosine; Temperature | 1995 |
Differential mechanism of block of palmitoyl lysophosphatidylcholine and of palmitoylcarnitine on inward rectifier K+ channels of guinea-pig ventricular myocytes.
Topics: Animals; Electrophysiology; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Lysophosphatidylcholines; Membrane Potentials; Palmitoylcarnitine; Perfusion; Potassium Channel Blockers; Potassium Channels | 1993 |
Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes.
Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Atrial Fibrillation; Calcium; Cardiac Pacing, Artificial; Cells, Cultured; Fatty Acids, Unsaturated; Heart; Lysophosphatidylcholines; Myocardial Contraction; Myocardium; Palmitoylcarnitine; Rats | 1996 |
Protective effects of dilazep and its derivative K-7259 on the haemolysis induced by amphiphiles in rat erythrocytes.
Topics: Animals; Dilazep; Erythrocytes; Hemolysis; Hypotonic Solutions; Lysophosphatidylcholines; Male; Micelles; Palmitoylcarnitine; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1997 |
Effects of arrhythmogenic lipid metabolites on the L-type calcium current of diabetic vs. non-diabetic rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electrophysiology; Ischemia; Lipid Metabolism; Lysophosphatidylcholines; Male; Myocardium; Palmitoylcarnitine; Patch-Clamp Techniques; Rats; Time Factors | 2001 |
Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Ethidium; Fluorometry; Humans; Interleukin-1beta; Lipids; Lysophosphatidylcholines; Mice; Octoxynol; Palmitoylcarnitine; Phosphorylcholine; Purinergic P2 Receptor Agonists; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X7; Sphingosine; Surface-Active Agents | 2007 |
UPLC‑QTOFMS‑based metabolomic analysis of the serum of hypoxic preconditioning mice.
Topics: Amino Acids; Animals; Chromatography, High Pressure Liquid; Discriminant Analysis; Disease Models, Animal; Hypoxia; Ischemic Preconditioning; Least-Squares Analysis; Lysophosphatidylcholines; Male; Metabolomics; Mice; Mice, Inbred BALB C; Palmitoylcarnitine; Principal Component Analysis; Spectrometry, Mass, Electrospray Ionization | 2017 |